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Abstract
Background: Little is known about risk factors upon hospital 
admission that are associated with in-hospital death of pa-
tients hospitalized for bacterial pneumonia. Identifying such 
factors may help to optimize the treatment and lower the 
mortality of these patients. Objectives: The aim of the study 
was to characterize baseline characteristics of patients hos-
pitalized for bacterial pneumonia in Switzerland and to iden-
tify risk factors associated with all-cause in-hospital mortal-
ity. Methods: Routinely collected electronic health record 
data of patients discharged from a large Swiss tertiary care 
hospital between August 2009 and 2017 were analysed. Po-
tential risk factors such as patient demographics, physical 
examination findings, vital signs, laboratory results, and co-
morbidities were considered within ±24 h of admission. Uni-
variable and multivariable logistic regression models identi-
fied risk factors for in-hospital death. The area under the re-
ceiver operating characteristic (ROC) curve was used to 
compare the identified factors to existing pneumonia scor-
ing systems. Results: Out of 1,781 hospital stays with initial 
and main diagnosis of bacterial pneumonia, 85 patients 
(4.85%) died (33.9% female, median age 62.3 years [inter-
quartile range, 52–75]). Age, low systolic blood pressure, un-
derweight, a missing value for body mass index, decreased 
haemoglobin level, raised C-reactive protein, high urea, high 
lactate dehydrogenase, concomitant pleural effusion, and 
cancer were independently associated with in-hospital 
death. The area under the ROC curve was 0.89 for the multi-
variable model containing the identified predictors. Conclu-
sions: Our data are consistent with previous trials character-
izing patients hospitalized for pneumonia. Additionally, we 
identified new and independent risk factors associated with 
in-hospital death among patients treated for bacterial pneu-
monia. Findings need to be further validated in larger multi-
centre cohorts. © 2020 The Author(s)
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According to the Global Burden of Diseases Study 
2017, lower respiratory tract infections, including bacte-
rial pneumonia, are the leading cause of death from com-
municable diseases worldwide [1]. Pneumonia scoring 
systems such as CURB-65 and Pneumonia Severity Index 
(PSI) help to determine the severity of community-ac-
quired pneumonia (CAP) and to identify low-risk pa-
tients who qualify for outpatient care [2, 3]. However, lit-
tle is known about risk factors upon hospital admission 
that are associated with in-hospital death of patients hos-
pitalized for bacterial pneumonia. Currently, no scoring 
system specifically predicting in-hospital death in pa-
tients treated for bacterial pneumonia, whether CAP or 
hospital-acquired pneumonia (HAP), exists. Rigorous 
management of bacterial pneumonia is essential, as it rep-
resents a life-threatening event, and by identifying risk 
factors, mortality may be decreased [4].
Purpose
The aim of the study is to characterize baseline demo-
graphics of patients hospitalized for bacterial pneumonia 
in Switzerland and to identify risk factors for in-hospital 
death from any cause (all-cause mortality).
Methods
Study Design and Study Population
The present study is a retrospective observational cohort study 
of prospectively collected electronic health care data at the Univer-
sity Hospital Zurich (USZ). USZ is a large 850-bed tertiary care 
academic medical centre located in Zurich, Switzerland. Data of 
hospitalized patients of at least 18 years of age discharged between 
August 2009 and 2017 were analysed. Out of all 287,255 hospital 
admissions (defined as cases), we included all cases admitted with 
bacterial pneumonia as the initial or main diagnosis, either (i) 
ICD-10-coded as J13*, J14*, J15*, and J18.1* (International Clas-
sification of Diseases, WHO, Geneva, Switzerland; asterisk means 
zero or more digits) or (ii) ICD-10-coded as J18.8* or J18.9* with 
a negative PCR test for seasonal respiratory viruses if performed 
on admission [5]. All other main diagnoses and outpatient cases 
were excluded. In the case of multiple admissions of 1 patient, all 
cases were included. The primary endpoint was defined as in-hos-
pital death irrespective of the length of in-hospital stay.
Measurements
Variables included in this report were patient demographics, 
physical examination findings, vital signs, laboratory results, and 
comorbidities. Only the first measured values within ±24 h of ad-
mission were considered for analyses. Relevant comorbidities ac-
cording to the literature [2, 6, 7] were defined based on validated 
algorithms using ICD-10 codes. Chronic heart failure, chronic ob-
structive pulmonary disease, asthma, hypertension, hypothyroid-
ism, dementia, diabetes mellitus, depression, alcohol misuse, and 
cancer (irrespective of metastatic status) were defined according to 
the algorithm by Tonelli et al. [8] for identifying chronic condi-
tions. Renal failure and liver disease were defined according to the 
coding algorithm by Quan et al. [9] for Elixhauser comorbidities. 
In addition, B20*, B21*, B22*, B23*, B24*, F02.4*, O98.7*, R75*, 
U60*, U61*, and Z21* defined HIV. J90* and J91* defined pleural 
effusion.
Data Sources
Data were ICD-10 coded and extracted from the data ware-
house at USZ. Extracted raw data were imported from “comma-
separated values” files into a database management system and 
processed using structured query language statements. 
Definitions
Body mass index (BMI) was categorized according to the 
World Health Organization definition [10] as underweight (BMI 
< 18.5 kg/m2), normal weight (BMI 20–25 kg/m2), and overweight 
(BMI > 25 kg/m2). Laboratory data were categorized according to 
the USZ laboratory standard values (reference values in online 
suppl. Table 1; see www.karger.com/doi/10.1159/000508666). 
Lactate dehydrogenase (LDH) was categorized as normal LDH 
(≤480 U/L) and high LDH (> 480 U/L). Urea was categorized age 
dependently as normal urea (< 60 years ≤7.14 mmol/L, 60–90 years ≤8.21 mmol/L, > 90 years ≤11.07 mmol/L) and high urea (< 60 
years > 7.14 mmol/L, 60–90 years > 8.21 mmol/L, > 90 years > 11.07 
mmol/L). For survival estimate, haemoglobin level was catego-
rized as low haemoglobin (< 11.7 g/dL) and normal haemoglobin 
(≥11.7 g/dL). For survival analysis using Kaplan-Meier estimates, 
C-reactive protein (CRP) was categorized according to quartiles 
into high CRP (4th quartile > 18.12 mg/dL) and low CRP (1st quar-
tile < 4.2 mg/dL). Continuous variables with > 20% missing values 
were stratified as categorical, including the category “NA” (not ap-
plicable) indicating the lack of a value. 
Statistical Analysis
Statistical analyses were performed using the software R, ver-
sion 3.5.1 (R Foundation for Statistical Computing, Vienna, Aus-
tria). Depending on normality of distribution, continuous vari-
ables were presented as mean ± SD or as median and interquartile 
range (IQR), and categorical variables as numbers (n) and percent-
ages (%). For significance testing of continuous variables between 
groups, t tests or Wilcoxon signed-rank tests were used. To com-
pare categorical variables, χ2 tests or Fisher’s exact tests were used. 
Univariable and multivariable logistic regression identified as-
sociated factors for in-hospital death. The criterion for inclusion 
in multivariable analysis was a significance level of p < 0.1 in the 
univariable analysis. Stepwise selection of variables was performed 
to find the best fitting model according to the Akaike information 
criterion. Only statistically significant predictors (p < 0.05) were 
retained in the final model. Results are presented as odds ratios 
(OR) with CI from 2.5 to 97.5%. The area under the receiver oper-
ating characteristic (ROC) curve (AUC) was calculated to assess 
the prognostic value of the selected predictors. 
For subgroup analysis, all cases were categorized based on the 
length of stay of ≤7 and > 7 days (cut-off at median length of stay 
of patients who died in hospital). Multivariable logistic regression 
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(n = 1,696; 95.2%)
Non-survivors
(n = 85; 4.8%)
p value
Age, years 65 (52–75) – 65 (52–75) 73 (66–81) <0.001
Sex, female 604 (33.9) – 583 (34.4) 21 (24.7) 0.085
Civil status 0.173
Married/partnered 952 (53.5) – 899 (53.0) 53 (62.4)
Single 374 (21.0) – 364 (21.5) 10 (11.8)
Widowed/divorced/separated 409 (23.0) – 389 (22.9) 20 (23.5)
Other/unknown 46 (2.6) – 44 (2.6) 2 (2.4)
Physical examination findings
BMI, kg/m2 25.22±8.11 826 (46.4) 25.28±8.19 23.22±4.89 0.163
Systolic BP, mm Hg 126.63±22.03 224 (12.6) 126.96±21.95 119.90±22.80 0.008
Diastolic BP, mm Hg 72.56±13.91 226 (12.7) 72.71±13.79 69.38±15.91 0.047
Body temperature, ° C 37.55±0.95 228 (12.8) 37.56±0.95 37.27±0.78 0.011
Laboratory findings
Haematocrit, % 36.0 (31.7–40.0) 13 (0.7) 36.10 (31.9–40.0) 31.0 (27.8–36.1) <0.001
Haemoglobin level, g/dL 12.0 (10.4–13.4) 13 (0.7) 12.00 (10.5–13.4) 10.2 (8.9–11.9) <0.001
White blood cell count, ×109/L 10.6 (7.4–14.6) 13 (0.7) 10.60 (7.4–14.5) 10.1 (7.3–15.7) 0.693
Neutrophil cell count, ×109/L 8.3 (5.5–12.1) 52 (2.9) 8.30 (5.5–12.1) 7.5 (5.0–12.7) 0.749
Lymphocyte count, ×109/L 0.9 (0.6–1.4) 125 (7.0) 0.90 (0.6–1.4) 0.8 (0.4–1.0) <0.001
Platelet count, ×109/L 228 (167–314) 13 (0.7) 228 (169–314) 233(137–345) 0.882
CRP, mg/dL 10.2 (4.2–18.1) 21 (1.2) 10.0 (4.1–17.9) 14.2 (7.0–24.6) 0.002
Creatinine level, µmol/L 89.0 (70.0–128.0) 61 (3.4) 89.0 (70.0–126.0) 100.5 (72.5–147.8) 0.088
Blood urea level, mmol/L 6.9 (4.6–10.7) 495 (27.8) 6.7 (4.6–10.3) 10.5 (6.7–15.2) <0.001
Blood glucose level, mmol/L 6.6 (5.6–8.1) 788 (44.2) 6.5 (5.6–8.1) 6.6 (5.9–8.5) 0.564
LDH, U/L 443 (359–565) 952 (53.5) 438 (356–552) 614 (465–907) <0.001
Sodium, mmol/L 136 (133–139) 45 (2.5) 136 (133–139) 135 (133–140) 0.535
Serum total protein, g/L 66.0 (61.0–71.0) 1,454 (81.6) 66.0 (61.0–71.25) 60.0 (54.5–70.5) 0.075
Albumin, g/L 35.0 (31.0–38.0) 1,019 (57.2) 35.0 (31.0–38.0) 30.0 (25.0–34.5) <0.001
AST, U/L 29.0 (22.0–41.0) 506 (28.4) 28.0 (22.0–40.0) 33.5 (25.3–57.0) 0.002
ALT, U/L 21.0 (15.0–36.0) 196 (11.0) 21.0 (15.0–36.0) 23.5 (13.0–39.3) 0.961
Comorbidities
Chronic heart failure 222 (12.5) – 205 (12.1) 17 (20.0) 0.047
Hypertension 718 (40.3) – 684 (40.3) 34 (40.0) 1
COPD 309 (17.3) – 294 (17.3) 15 (17.6) 1
Asthma 51 (2.9) – 50 (2.9) 1 (1.2) 0.534
Cancer 309 (17.3) – 273 (16.1) 36 (42.4) <0.001
Renal failure 502 (28.2) – 471 (27.8) 31 (36.5) 0.106
Liver disease 80 (4.5) – 76 (4.5) 4 (4.7) 1
Diabetes mellitus 329 (18.5) – 314 (18.5) 15 (17.6) 0.954
Hypothyroidism 128 (7.2) – 125 (7.4) 3 (3.5) 0.262
Dementia 59 (3.3) – 52 (3.1) 7 (8.2) 0.022
Depression 123 (6.9) – 117 (6.9) 6 (7.1) 1
Alcohol misuse 48 (2.7) – 46 (2.7) 2 (2.4) 1
HIV 73 (4.1) – 73 (4.3) 0 (0.0) 0.094
Pleural effusion 176 (9.9) – 155 (9.1) 21 (24.7) <0.001
Comorbidities, n 1.77±1.39 – 1.75±1.37 2.33±1.62 <0.001
Previous admissions, n
Within the last 2 years 1.76±2.36 – 1.74±2.36 2.11±2.29 0.199
Within the last year 1.08±1.57 – 1.06±1.56 1.54±1.76 0.009
Within the last 6 months 0.67±1.08 – 0.65±1.07 1.01±1.20 0.003
Within the last 90 days 0.40±0.75 – 0.39±0.74 0.65±0.90 0.001
Within the last 30 days 0.17±0.43 – 0.16±0.42 0.36±0.53 <0.001
Length of stay, days 8 (5–12) – 8 (5–12) 7 (3–13) 0.219
Continuous data are expressed as mean ± SD or median (IQR) where appropriate. Categorical data are expressed as n (%). Laboratory reference values 
are displayed in Supplement Table 1. NA, not available; BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; LDH, lactate dehydrogenase; 





of the previously identified factors associated with in-hospital 
death was performed on both subgroups. Additionally, Kaplan-
Meier estimate was calculated for overall survival based on the 
length of in-hospital stay. The log-rank test was used to compare 
Kaplan-Meier estimates. Significance was accepted for p < 0.05. 
Results
Study Cohort and Baseline Characteristics
We identified 1,781 cases admitted for bacterial pneu-
monia. Overall median age was 65 years (IQR 52–75) and 
604 (33.9%) were female. The overall median length of 
stay until either in-hospital death or discharge from hos-
pital was 8 days (IQR 5–12). Table 1 summarizes baseline 
characteristics of the study cohort stratified by survival 
(survivors, 95.2%) and in-hospital death (non-survivors, 
4.8%). Compared to survivors, non-survivors were signif-
icantly older, had a lower systolic and diastolic blood pres-
sure, a lower haematocrit and haemoglobin level, a lower 
lymphocyte count, and a lower albumin level. In contrast, 
non-survivors had a significantly higher CRP level, a high-
er LDH level, a higher blood urea level, and a higher AST 
level. Chronic heart failure, cancer, dementia, and pleural 
effusion were more common in non-survivors. Non-sur-
vivors also had significantly more comorbidities and were 
more often hospitalized in the previous year. 
Risk Factors of In-Hospital Mortality
For prediction of in-hospital mortality, 43 variables 
were analysed. Of these, 25 variables with a p value < 0.1 
in univariable analysis qualified for multivariable analy-
sis. In a stepwise multivariable logistic regression analy-
sis, we identified 10 independent factors associated with 
all-cause in-hospital death of patients hospitalized for the 
Table 2. Multivariable logistic regression analysis
Variables Univariable analysis Multivariable analysis
OR 95% CI p value OR 95% CI p value
Age, years 1.04 1.03–1.06 <0.001 1.07 1.04–1.10 <0.001
Systolic BP 0.98 0.97–1.00 0.008 0.98 0.96–0.99 0.009
Normal weight Ref. Ref.
Underweight 3.51 1.36–8.50 0.006 6.08 1.84–19.68 0.003
NA BMI 2.21 1.25–4.17 0.010 2.96 1.39–6.90 0.007
Haemoglobin level 0.77 0.69–0.85 <0.001 0.83 0.71–0.95 0.009
CRP 1.03 1.01–1.05 <0.001 1.04 1.01–1.07 0.002
Normal LDH Ref. Ref.
High LDH 4.42 2.44–8.41 <0.001 5.12 2.26–12.61 <0.001
Normal urea Ref. Ref.
High urea 3.22 1.95–5.47 <0.001 2.11 1.08–4.24 0.031
Cancer 3.83 2.43–5.99 <0.001 3.22 1.73–5.99 <0.001
Pleural effusion 3.26 1.90–5.40 <0.001 3.35 1.63–6.65 <0.001
Definitions: high LDH (>480 U/L), high urea (<60 years >7.14 mmol/L, 60–90 years >8.21 mmol/L, >90 years 
>11.07 mmol/L). OR, odds ratio; CI, confidence interval; BP, blood pressure; BMI, body mass index; Ref., 




















Fig. 1. ROC curve for in-hospital death for the identified risk fac-
tors in Table 2.
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treatment of bacterial pneumonia (Table 2). Factors were 
age, low systolic blood pressure, underweight, a missing 
value for BMI (NA BMI), decreased haemoglobin level, 
raised CRP level, high urea, high LDH, concomitant pleu-
ral effusion, and cancer. For the identified risk factors 
above, the AUC of the multivariable logistic regression 
model was 0.89 (Fig. 1). 
Prognostic Factors of In-Hospital Death Stratified by 
Length of Stay
Patients who stayed > 7 days were significantly older 
(68 vs. 63 years, p < 0.001), had an increased LDH level 
(450 vs. 435.5 U/L, p = 0.014) and suffered more often of 
concomitant pleural effusion (14.7 vs. 4.8%, p < 0.001) 
than patients who stayed ≤7 days in hospital. Addition-
ally, the former had multiple comorbidities (2.16 vs. 1.36, 
p < 0.001). However, there was no significant difference 
in the prevalence of cancer (17.8 vs. 16.8%, p = 0.612) in 
both subgroups. Table 3 compares in a multivariable sub-
group analysis all cases with a length of stay ≤7 days (n = 
862) to those with a length of stay > 7 days (n = 919). Age, 
decreased haemoglobin level, raised CRP level, high LDH, 
high urea, and a concomitant pleural effusion are signifi-
cantly associated with in-hospital death within the first 7 
days. Of these factors, age, high LDH, and concomitant 
pleural effusion were still associated with death after 7 
days. Additionally, systolic and diastolic blood pressure, 
underweight, and cancer are significantly associated with 
death after 7 days of in-hospital stay.
Estimates of Survival
Figure 2 shows the Kaplan-Meier survival curve of 4 
stratified and previously identified factors associated with 
in-hospital death for 21 days: underweight, high LDH, 
low haemoglobin, and high CRP. p values were statisti-




Of the factors identified, age, systolic blood pressure, 
blood urea level, cancer, and concomitant pleural effu-
sion are included in either the PSI score [3] or the CURB-
65 score [2]. In addition, we found increased CRP level, 
decreased haemoglobin level, high LDH level, and under-
weight or a missing value for BMI to be significantly as-
sociated with in-hospital death. In Figure 2, we highlight-
ed again the identified risk factors for in-hospital death in 
4 Kaplan-Meier survival curves of variables not present in 
the CURB-65 or PSI score.
Table 3. Multivariable logistic regression analysis based on length of stay
Variables ≤7 days 
(n = 862 cases, n = 47 deaths)
>7 days 
(n = 919 cases, n = 38 deaths)
OR 95% CI p value OR 95% CI p value
Age, years 1.06 1.03–1.10 <0.001 1.06 1.02–1.10 <0.004
Systolic BP 0.98 0.95–1.00 <0.087 0.97 0.94–1.00 <0.023
Diastolic BP 1.00 0.96–1.04 <0.902 1.06 1.02–1.11 <0.007
Norm. weight Ref. Ref.
Underweight 3.79 0.69–18.97 <0.109 6.70 1.18–36.07 <0.026
NA BMI 1.99 0.76–5.81 <0.179 2.60 0.90–8.91 <0.097
Haemoglobin level 0.77 0.63–0.94 <0.011 0.80 0.63–1.00 <0.052
CRP 1.05 1.01–1.08 <0.009 1.03 0.99–1.06 <0.176
Norm LDH Ref. Ref.
High LDH 4.32 1.49–14.12 <0.010 4.48 1.31–18.44 <0.023
Norm urea Ref. Ref.
High urea 3.03 1.26–7.68 <0.015 1.41 0.54–3.77 <0.485
Cancer 2.25 0.93–5.40 <0.069 5.78 2.47–14.00 <0.001
Pleural effusion 3.77 0.92–13.17 <0.047 5.27 2.20–12.59 <0.001
Definitions: high LDH (>480 U/L), high urea (<60 years >7.14 mmol/L, 60–90 years >8.21 mmol/L, >90 years 
>11.07 mmol/L). OR, odds ratio; CI, confidence interval; BP, blood pressure; BMI, body mass index; NA, missing 





Lee et al. [7] previously described the role of a raised 
CRP as an independent predictor of 28-day mortality. 
However, their cut-off defining high CRP was set at 14.3 
mg/dL and if added to the CURB-65 score, no additional 
effect was observed. 
The association of anaemia with excess mortality in 
patients treated for various diseases including pneumo-
nia was previously outlined [11–14]. This finding has 
been considered by the PSI score through the variable 
haematocrit, but not by haemoglobin level, which was, in 
our study, significantly associated with in-hospital death 
if decreased.
High LDH has been described as a predictor of mortal-
ity in patients with AIDS and Pneumocystis carinii pneu-
monia, but not in bacterial pneumonia [15]. Initial high 
LDH level might be the consequence of chronic heart fail-
ure, liver damage, cancer, or sepsis and is a well-known 
unspecific marker for tissue damage [16]. In-hospital 
death is possibly associated with the underlying cause that 
leads to increased LDH, but not due to LDH itself. Nev-
ertheless, liver diseases and markers of liver injuries such 
as AST, ALT, and albumin did not turn out to be signifi-
cantly associated with in-hospital death in multivariable 
analysis. Multivariable regression showed an indepen-
dent association of cancer and of high LDH with in-hos-
pital death.
Our fourth novel risk factor for in-hospital mortality 
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Fig. 2. Kaplan-Meier survival curve of 4 stratified and previously 
identified factors associated with in-hospital death for 21 days. a 
Comparison of underweight patients (BMI < 18.5 kg/m2) and pa-
tients with missing BMI values (BMI NA) vs. obese, normal, and 
overweight patients (BMI ≥20 kg/m2). NA, not applicable. b Com-
parison of patients with initial high LDH (> 480 U/L) vs. patients 
with initial normal LDH (≤480 U/L). c Comparison of patients 
with initial low haemoglobin (< 11.7 g/dL) vs. patients with initial 
normal haemoglobin (≥11.7 g/dL). d Comparison of patients with 
initial high CRP (> 18.12 mg/dL) vs. patients with initial low CRP 
(< 4.2 mg/dL).
Risk Factors of Mortality in Pneumonia 7Respiration
DOI: 10.1159/000508666
derweight. NA BMI can be explained by severity of dis-
ease and consecutive immobilization and, therefore, 
omission of measuring the weight on a scale. Under-
weight, on the other hand, is potentially related to malnu-
trition and cachexia, or other health issues such as hypal-
buminaemia which was previously identified as a predic-
tor for mortality in CAP [17]. However, the association 
of low albumin and mortality was not statistically signifi-
cant in our study cohort.
In subgroup analysis, we found a different set of prog-
nostic factors based on the length of in-hospital stay of ≤7 
and > 7 days (Table 3). At initial presentation, haemoglobin 
level, CRP, and urea only seem to have a prognostic value 
within the first 7 days of in-hospital stay. After 7 days, we 
found underweight and cancer to be independently associ-
ated with in-hospital death. These factors might be associ-
ated with in-hospital death irrespective of pneumonia [18, 
19]. On the other hand, cancer has previously been found 
to be a predictor of poor prognosis in CAP [20].
Comparison to Previous Studies
All-cause mortality in our study (4.8%) was lower 
compared to similar relevant studies in Europe (9.1%), 
USA/Canada (7.3%), Latin America (13.3%), and South 
Korea (9.3%) [17, 21]. However, the prevalence of most 
comorbidities was lower, which might explain the differ-
ence. On the other hand, in a study validating the PSI 
score, in-hospital mortality was lower despite having sim-
ilar baseline characteristics [6]. A recent study comparing 
mortality rates of pneumonia in the European Union be-
tween 2001 and 2014 showed higher mortality rates in 
most countries than in Switzerland. The authors also did 
not distinguish between CAP and HAP using a similar 
approach based on ICD-10 codes [22]. The overall me-
dian length of stay was 8 days, and the median length of 
stay of patients who died in-hospital was 7 days (p = 0.219; 
Table 1). These findings seem to be congruent with re-
lated studies on pneumonia [23, 24]. Based on this, we 
defined the cut-off in subgroup analysis (Table 3). With 
an AUC of 0.89, our identified risk factors seem to have a 
higher discriminatory power in predicting mortality than 
existing pneumonia scoring systems. In another study, 
AUC for predicting mortality was 0.81 for PSI, 0.73 for 
CURB, and 0.76 for CURB-65 score [25]. However, direct 
comparison is not possible, mainly due to heterogeneous 
cohorts and the fact that CURB-65 and PSI score includ-
ed ambulatory patients. Finally, variables included in the 
CURB-65 score such as respiratory rate or confusion are 
missing in our study. 
Strengths
Data were routinely collected and extracted from elec-
tronic health records and therefore we did not have influ-
ence on the variables collected. 
The identified factors are relevant for daily clinical 
practice and may help identifying patients at risk of in-
hospital death. Physicians especially need to consider rel-
evant comorbidities such as cancer and concomitant pleu-
ral effusion [26]. The studied period of 8 years is the 
longest compared to pneumonia-related studies in 
Switzerland and Europe. In contrast to other studies, we 
did not exclude patients due to other conditions such as 
previous admissions or a certain comorbidity [2, 3, 7]. 
Therefore, the study reflects the real-life scenario with an 
examination of a broad range of clinically relevant vari-
ables in a large cohort compared to related studies. Results 
are likely to be transferable to other hospital settings in 
Europe.
Limitations
All data come from a single tertiary care hospital and 
thus potential selection bias and referral bias cannot be 
excluded. Sample size varies among different variables 
depending on the individual health care provider order-
ing specific tests on admission. This concerns particular-
ly physical examination findings and laboratory values. 
However, patient demographics, comorbidities and, im-
portantly, recordings of in-hospital death were complete. 
CRP was classified as a categorical variable for survival 
analysis by Kaplan-Meier estimate. Since a dichotomous 
classification using the clinical validated cut-off of 5 mg/L 
would have resulted in too much simplification, we chose 
to use categorization according to quartiles.
Since microbiology results were not available in the cur-
rent study, our approach to identify patients with bacterial 
pneumonia was based on ICD-10 codes. However, ICD-10 
codes were added to the diagnoses after patient discharge, 
and no information was available on whether pneumonia 
was present on admission or occurred later in the stay. 
Consequently, we could not distinguish between CAP and 
HAP, but included all cases coded as bacterial pneumonia 
and excluded those with positive PCR for respiratory vi-
ruses. Therefore, in cases with HAP a prediction of in-hos-
pital mortality based on variables at initial presentation is 
not possible. However, according to a recent study in Swit-
zerland, the estimated incidence of HAP is up to 15 times 
lower than the incidence of CAP, making the proportion 
of potential cases with HAP in our study population con-
siderably small [27]. Ultimately, a validation cohort study 





The identified predictors of mortality cannot be ap-
plied to outpatients due to exclusion. In addition, not all 
variables found in existing pneumonia scores were pres-
ent. Validation of CURB-65 or PSI score was therefore 
not possible. Our results have not been validated yet in 
other cohorts. More data are required, preferably from 
multiple hospitals, to validate our findings. 
Conclusion
This study identified 10 independent risk factors of in-
hospital mortality in patients treated for bacterial pneu-
monia. Of these, raised CRP level, decreased haemoglobin 
level, high LDH level, and underweight or a missing value 
for BMI are currently not represented in other pneumonia 
scoring systems. These results are compatible with large 
multicentre trials and add additional value and insight 
into the efforts of reducing mortality of hospitalized pa-
tients treated for bacterial pneumonia. However, findings 
need to be validated in larger multicentre cohorts.
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